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Abstract
The 30-50-cyclic guanosine monophosphate (cGMP)-dependent protein kinase (PKG) is the main mediator of cGMP signalling in the malaria
parasite. This article reviews the role of PKG in Plasmodium falciparum during gametogenesis and blood stage schizont rupture, as well as the
role of the Plasmodium berghei orthologue in ookinete differentiation and motility, and liver stage schizont development. The current views on
potential effector proteins downstream of PKG and the mechanisms that may regulate cyclic nucleotide levels are presented.
 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
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1. Guanylyl cyclases and cGMP-phosphodiesterases
The intracellular second messenger cGMP regulates
downstream targets, thereby influencing diverse cellular
functions, ranging from smooth muscle contractility [1], to
retinal phototransduction [2]. cGMP is synthesised by gua-
nylyl cyclases (GCs) and hydrolysed by phosphodiesterases
(PDEs). In mammalian cells, natriuretic peptides ANP, BNP
and CNP activate membrane-bound GCs, while the soluble
GC is believed to be the main intracellular receptor of nitric
oxide (NO) [3]. Signalling mechanisms upstream of malaria
parasite GCs and the identity of potential membrane receptors
that may be able to react to environmental cues and initiate
intracellular signalling, remain largely unknown. It is possible
that rather than being coupled to receptors, the membrane-
bound GCs themselves may be able to receive an extra- or
intracellular signal. In Plasmodium, there is no soluble GC and
the membrane-bound GCs do not appear to contain an NO-
binding domain and so it is unclear, whether NO impacts on
cGMP signalling in the parasite.
Due to evolutionary early branching, the apicomplexan
components of cGMP signalling are much diverged from the
mammalian enzymes. In Plasmodium falciparum, two
membrane-associated GC isoforms (PfGCa and PfGCb) have
been identified [4]. These are unusual predicted bifunctional
enzymes with up to 22 transmembrane domains; comprising
an N-terminal P-type ATPase-like domain (resembling
a calcium pump) and a paired C-terminal GC domain that has
a similar topology to mammalian G protein coupled adenylyl
cyclases [4,6]. Recombinant expression of the two catalytic
domains of PfGCb demonstrated guanylyl cyclase activity, but
no adenylyl cyclase activity [4]. Low levels of PfGCa mRNA
expression have been detected in sexual and asexual blood
stages by microarray analysis [5,7]. Immunoelectron micros-
copy using an antibody raised to the catalytic domain of
PfGCa suggested that the enzyme may be located in the
parasitophorous vacuole membrane (PVM) or the plasma
membrane of gametocytes [4]. GCa orthologues from P. fal-
ciparum and Plasmodium berghei are both refractory to
deletion and are therefore likely to have an essential function
in the development of erythrocytic asexual stages [4,8]. PfGCb
is transcribed at relatively high levels in mature gametocytes,
but not in asexual blood stages. The gene was successfully
disrupted implying no essential function in the blood stages.
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PfGCb-ko lines also exhibited no significant effects on the
development of gametocytes or gametogenesis [8], consistent
with results obtained by deleting the P. berghei orthologue [9].
In P. falciparum, four genes encode cyclic nucleotide PDEs
(PfPDEa, PfPDEb, PfPDEg and PfPDEd). PfPDEa is
expressed as two alternatively spliced isoforms (PfPDEaA and
PfPDEaB). All four PfPDEs are predicted to comprise 4e6
transmembrane domains, consistent with the finding that most
of the PDE activity is present in crude membrane fractions of
blood stage parasites [10,11]. This is in contrast to mammalian
cells, where few PDEs contain a transmembrane domain [12].
There is biochemical and genetic evidence that PfPDEa and
PfPDEd hydrolyse cGMP [8,10,11,13]. Deletion of PfPDEa
showed that it is not an essential gene in blood stages, since
parasites had no aberrant phenotype. However, cGMP-
hydrolysing activity in PfPDEa-ko parasites was reduced by
20%, while cAMP-hydrolysis was unaffected [11], consistent
with data showing that the catalytic domain of PfPDEa as
a recombinant protein has cGMP-PDE activity [10,11]. These
data also suggest that at least one other PDE breaks down
cGMP in P. falciparum blood stages. The most plausible
candidate is PfPDEb, since this is the only other PfPDE highly
expressed in blood stages [14]. High levels of cAMP-specific
PDE activity have been measured in the asexual blood stages
of P. falciparum, suggesting that PfPDEb may be a dual
specificity phosphodiesterase [11,15]. PfPDEg mRNA
expression is detectable at low levels in asexual blood stage
parasites [11], but was successfully knocked out in P. falci-
parum, without obvious morphological effects in asexual or
sexual blood stages [8]. PfPDEd mRNA is expressed at high
levels in gametocytes and while a knockout was also possible,
indicating a non-essential role in asexual stages, severe effects
on gametogenesis and a 50% reduction of cGMP-PDE activity
were observed [8].
While the cGMP-dependent protein kinase (PKG) is
believed to be the main target of cGMP, mammalian cells have
other proteins that are directly regulated by cGMP, such as
cyclic nucleotide-gated ion channels and proteins containing
a small molecule and nucleotide binding GAF domain, which
in some cases binds to cGMP [16]. Plasmodium genomes,
each have a single gene encoding PKG, but no cGMP-
responsive ion channel was identified [17,18]. An additional
protein has been identified (PlasmoDB identifier: PF14_0173,
PBANKA_102530) with five putative cyclic nucleotide
binding domains, of which the most C-terminal domain is
predicted to have cGMP-specificity [13]. The predicted
>400 kDa protein is conserved among apicomplexan parasites
and its expression has been detected in P. falciparum [19,20].
No conserved effector function can be annotated, but inter-
estingly the protein has homology with reticulocyte binding
proteins. The remainder of this review will focus on the only
characterised cGMP regulated protein in Plasmodium, PKG.
2. The apicomplexan cGMP-dependent protein kinase
Two genes encode mammalian PKG, type I and II, and two
PKG I isoforms are generated by alternative splicing (PKG-Ia
and PKG-Ib) [21]. PKG-I is cytosolic, whereas PKG-II
undergoes myristoylation at an N-terminal glycine residue
that facilitates anchoring to the plasma membrane [21].
Mammalian PKG is a homodimer, with each monomer
comprising both a regulatory and a catalytic domain. An
autoinhibitory domain, that is part of the regulatory subdomain
of PKG, interacts with and inhibits the catalytic subunit in the
absence of cGMP. Upon cGMP-binding to the regulatory
domain, a conformational change releases the catalytic
domain, leading to activation of the kinase [21,22]. No 3D
structural data exist for full length PKG to date, however,
crystallographic data are available for the leucine zipper and
GKAP docking site of PKG-Ib [23] and the N-terminal cyclic
nucleotide binding domain [24].
The apicomplexan parasites Toxoplasma gondii and Eime-
ria tenella both have a single PKG gene copy, but express two
isoforms as a result of alternative translation start sites. The
shorter isoform localises to the cytosol, while the full length
protein undergoes N-terminal myristoylation and palmitoyla-
tion, reminiscent of the mammalian PKG II [18]. The single
copy P. falciparum PKG (PfPKG; PlasmoDB identifier
PF14_0346) lacks the consensus motifs for N-terminal myr-
istoylation and palmitoylation [25]. There are structural
features, distinct from mammalian cells that are conserved
across the apicomplexan PKGs. First, they lack the N-terminal
leucine zipper motif present in mammalian PKG, which is
thought to mediate homodimerisation, as well as interaction
with other proteins, including some substrates. Evidence
suggests that the apicomplexan PKGs are monomeric, in
contrast to the mammalian isoforms [18]. Interestingly, the P.
falciparum PKG does have a motif towards the N-terminus of
the protein that resembles the pseudosubstrate sequence of
mammalian autoinhibitory domains [26], although a regula-
tory role for this has not been demonstrated.
Another distinction concerns the number of cGMP-binding
sites in the regulatory domain. Mammalian PKGs contain two
cGMP-binding sites whereas apicomplexan isoforms contain
an additional, third, cGMP-binding site and a degenerate
fourth which lacks key cGMP-binding residues. Mutation of
the third cGMP-binding site had the greatest effect on the
Ka(cGMP) [27]. In the same study mutation of the fourth,
degenerate, site was shown to cause a decrease in the
maximal enzymatic rate, but with no corresponding decrease
in Ka(cGMP). This led to the conclusion that this site is
required for full activation, but does not bind cGMP [27]. For
the E. tenella PKG (EtPKG) and PfPKG expressed in T.
gondii, as well as for TgPKG, a relatively high degree of
cooperativity of cGMP-dependent activation of PKG has been
measured [25].
The behaviour with respect to cGMP analogues is also
different. In contrast to mammalian PKGs, 8-substituted
cGMP analogues are only weak activators of the EtPKG
[28] and P. falciparum PKG [27]. Since apicomplexan PKGs
were found to require binding to all three cGMP-binding
domains for full activation, a restricted binding of the 8-
substituted analogue to the unusual additional (third)
cGMP-binding site was assumed [28]. PET-cGMP proved
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to be a relatively good activator of apicomplexan PKG
enzymes [27,28] and this cGMP analogue may potentially be
used as a molecular tool to trigger PKG activity in these
systems.
There are differing reports on the stage specificity of
PfPKG protein expression. Initially peak expression was
documented in P. falciparum ring stage parasites as well as in
gametocytes [8,17,25]. More recent work has found maximal
asexual blood stage expression of PfPKG protein in late
trophozoites and schizonts [29,30].
3. PfPKG mediates the initiation of P. falciparum
gametogenesis
A small percentage of erythrocytic malaria parasites
develop into gametocytes, the sexual stages, which are taken
up by feeding mosquitoes and are responsible for transmission
from the human to the mosquito host. As soon as the game-
tocytes are inside the insect, environmental changes are
believed to immediately trigger gametogenesis; the differen-
tiation to the mature gamete stage. Both male and female
gametocytes change their morphology from crescent-shaped
to spherical by rounding up, following which the male
undergoes three rounds of genome replication to produce
eight flagellated gametes, which then egress in a process
termed exflagellation. This process can be stimulated in vitro
by a temperature-decrease combined with either a rise in pH
or addition of the mosquito-derived factor xanthurenic acid
(XA) [31,32]. It is unclear how the stimulatory XA-signal is
received by gametocytes. Pharmacological evidence sug-
gested that increased cGMP levels could stimulate exfla-
gellation in P. berghei and P. falciparum [33]. Furthermore
a link between the stimulation of exflagellation by XA and
cGMP-synthesis was identified, when addition of XA to P.
falciparum gametocyte membrane preparations was found to
stimulate GC activity [34]. This suggests that the signal for
exflagellation might be transduced via a cGMP-mediated
pathway [34] and that the membrane-associated GCs might
directly or indirectly be involved in the reception of the XA-
signal.
Since gametogenesis (and asexual blood stage develop-
ment) was apparently normal in GCb-ko parasites despite
a decrease in GC activity in both P. falciparum [8] and P.
berghei [9] parasites, this suggests that the critical cGMP-
generating enzyme in both these stages is PfGCa [8,35,36],
which was refractory to knockout approaches. Upon disruption
of PfPDEd, which is expressed in gametocytes, the cGMP-
PDE activity was decreased by approximately 50% and the
ability of gametocytes to round up and undergo exflagellation
in the presence of XA was severely reduced [8]. Interestingly,
it appeared that egress of the PfPDEd-ko gametes from the
RBC was significantly inhibited [8]. It was concluded that
disruption of cGMP-PDE activity likely disturbs gametogen-
esis as a result of premature activation of PfPKG [8]. This
indicated that a tight temporal regulation of cGMP levels by
GC and PDE activities is crucial for successful sexual stage
development [8].
3.1. A chemical genetic tool to demonstrate a role for
PKG in gametogenesis
Since both PfPKG and PbPKG have proved refractory to
deletion, an essential role for the enzyme in the asexual blood
stages was assumed [8]. However, the lack of availability of
a gene knockout has required the development of an alterna-
tive set of chemical genetic tools to study PKG function in the
blood stages.
Valuable data have been generated using the PKG selective
small molecules, compound 1 and compound 2 in combination
with inhibitor-resistant transgenic parasites. The trisubstituted
pyrrole 4-[2-(4-fluorophenyl)-5-(1-methylpiperidine-4-yl)-1H-
pyrrol-3-yl]pyridine (compound 1) was identified in a whole-
cell screen by Merck Research Laboratories and inhibits the
growth of the coccidian parasites E. tenella and T. gondii both
in vitro and in vivo [18,37]. In a chemical pull-down assay
with compound 1, PKG was identified as a molecular target of
compound 1 in E. tenella parasites [18]. In a subsequent
medicinal chemistry effort, a more potent PKG inhibitor, the
imidazopyridine compound 4-[7-[(dimethylamino) methyl]-2-
(4-fluorophenyl) imidazo[1,2-a] pyridin-3-yl] pyrimidin-2-
amine (compound 2) was developed and had greater efficacy
in both in vitro and in vivo assays [38]. The selectivity of
compound 1 for apicomplexan PKGs, has been attributed to
interaction of a fluorophenyl group with a hydrophobic pocket
that is part of the ATP-binding site. This pocket is accessible
as a result of a relatively small residue threonine in the gate-
keeper position, which is present in apicomplexan PKGs, but
not in the mammalian isoforms [39]. An approach first used to
investigate ‘off-target’ effects of the PKG inhibitors in the
T. gondii parasite [39] was also employed to study the malarial
enzyme. The gatekeeper residue of the endogenous PfPKG
(threonine 618) was mutated to a bulkier glutamine. This
single substitution increased the IC50 of compound 1 more
than 3000 fold in kinase assays using recombinant enzyme.
The mutant PKG was then introduced into P. falciparum by
allelic replacement to allow investigation of the function of
PKG in the various life cycle stages by comparison of mutant
and wild-type parasites after treatment with compound 1 and
2 [35].
Selective chemical inhibition of PfPKG function by
compound 1 and compound 2 [18] has allowed evaluation of
the role of PfPKG during gametogenesis [35]. These PKG
inhibitors were found to prevent both rounding up and exfla-
gellation in P. falciparum gametocytes in the low micromolar
range. Use of the genetically derived gatekeeper mutant of
PKG confirmed that PfPKG is the primary target of compound
1 and 2 during the initiation of gametogenesis and showed that
activation of gametocytes is mediated by PfPKG [35].
4. Function of cGMP signalling in the regulation of
ookinete development and motility
Following fertilisation of the gamete in the mosquito
midgut, the zygote develops into an ookinete which requires
gliding motility to traverse the midgut epithelium. An essential
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role for cGMP signalling has been demonstrated for P. berghei
ookinete motility. In two separate studies, the PbGCb gene
was disrupted [13,9]. The observations were similar: ookinetes
appeared morphologically normal, but had a severe defect in
gliding motility and a drastically reduced ability to invade the
mosquito midgut, suggesting a role for cGMP-mediated sig-
nalling at this life cycle stage [13,9]. In accordance with this,
disruption of the PbPDEd gene resulted in initially normal
sexual development, but instead of developing to the normal
‘banana’ shape, ookinetes gradually became spherical with
a defect in motility and a greatly reduced midgut infection rate
[40]. The similarities between these two phenotypes point to
a requirement for tight control of cGMP levels to regulate
ookinete development and motility. Low levels of cGMP as
a result of a lack in GC activity, as well high cGMP levels due
to a lack of PDE-mediated degradation, both could lead to
a misregulation of PKG activity and cause the motility defect
in ookinetes. Evidence of a direct link to PKG was obtained
using compound 1, which is able to block ookinete gliding at
sub- to low micromolar concentrations, indicating that the
cGMP-pathway, through the actions of PKG, is crucial for
ookinete motility [13]. Further evidence for this link comes
from the ability of compound 1 to rescue PbPDEd-ko parasites
at this life cycle stage. It is hypothesised that PKG is over-
activated in the PbPDEd-ko parasites and therefore the
compound 1-mediated inhibition of PKG activity allows
normal development [13]. The PbPDEd-ko phenotype is also
reversed in P. berghei ookinetes, in which both PbGCb and
PbPDEd were disrupted simultaneously, possibly because the
decrease in cGMP-degradation can compensate for reduced
cGMP-synthesis [13]. Interestingly, in the P. berghei parasite,
a PbCDPK3-ko ookinete was found to mimic the reduced
gliding speed phenotype of the PbGCb-ko [9,36,40,41], sug-
gesting that calcium- and cGMP-dependent pathways might
overlap [13]. In accordance with this was the observation that
the increased cytosolic cGMP level in the PbPDEd-ko was
able to rescue the phenotype of PbCDPK3-ko, resulting in
normal motility, possibly because overstimulation of PbPKG
can compensate for the loss of PbCDPK3 signalling [13].
5. PbPKG function is involved in merosome release at the
liver stage of P. berghei
After invasion of a liver cell, the malarial sporozoite
replicates and eventually merozoites exit the infected hepa-
tocyte in vesicles called merosomes, containing hundreds of
parasites, which bud off the membrane. An elegant genetic
knockout of PbPKG has been described in the liver stages of
the parasite life cycle. In this approach, flippase recognition
sites were introduced into the PbPKG locus, allowing
a temperature-dependent flippase to be expressed under
control of the stage-specific PbTRAP promoter. This leads to
disruption of the locus only upon reaching the sporozoite
stage, when infected mosquitoes were transferred to a lower
temperature, in the range of 25e30 C, prior to a blood-feed
[42]. These PbPKG-ko sporozoites were capable of infecting
hepatocytes and developing to the mature schizont stage, but
merosome release was dramatically reduced [42], suggesting
that similar to asexual blood stage schizonts, liver stage
schizont egress is regulated through the actions of PKG.
The PKG inhibitor compound 1 was used to investigate the
role of PbPKG during hepatocyte invasion by sporozoites [43].
Since PbPKG-ko sporozoites were capable of invading hepa-
tocytes [42], an inhibitory effect of compound 1 on sporozoite
invasion was unexpected [42], and together with the obser-
vation that PbPKG-ko sporozoites remained susceptible to
compound 1, strongly indicated alternative targets of the
inhibitor at this life cycle stage [43]. Pre-treatment of hepa-
tocytes with the inhibitor had no effect, which pointed to the
presence of compound-targets in the sporozoite, rather than
the host cell. Interestingly, E. tenella sporozoite invasion was
also prevented by compound 1 [44].
6. PfPKG is essential for merozoite egress from the blood
stage schizont
The relevance of cGMP signalling in Plasmodium asexual
blood stages has been assessed by studying the primary
effector molecule PKG and both GC and PDE enzymes using
genetic approaches. It was concluded that in asexual blood
stages, GCa may be responsible for cGMP-synthesis [4,8], and
PfPDEa and PfPDEb are thought to be the primary cGMP-
hydrolysing enzymes [14]. The PKG gene is refractory to
deletion in both P. falciparum and P. berghei [8] and together
with data from a chemical genetic approach [30], a crucial role
for PfPKG in the late stages of blood stage schizont matura-
tion became evident. The PKG inhibitor compound 1 was
found to inhibit growth of P. falciparum asexual blood stages
in vitro in the low mM range (IC50 of 2.70 mM  0.17) [30] and
it was active against recombinant and native PfPKG enzyme in
the low nanomolar range [25,35]. Parasites treated with either
this inhibitor or compound 2 were able to form mature
schizonts, but they were unable to rupture [30]. Direct
evidence that PfPKG is the primary target of the inhibitors was
generated using the T618Q gatekeeper mutant transgenic line
described earlier [30]. The subcellular locations of the several
schizont/merozoite proteins (merozoite surface protein 1
[PfMSP1] and rhoptry neck protein 4 [PfRON4, Pf225] [30],
apical membrane antigen 1 [PfAMA1], erythrocyte binding
antigen 175 [PfEBA175] and glideosome associated protein 45
[PfGAP45] [29]) involved in invasion and egress appeared
normal after compound 1 treatment, suggesting a function for
PfPKG very late in schizont development.
7. Potential molecular mechanisms regulated by PfPKG
PKG appears to have a crucial role in preparing the parasite
for egress from the host cell at the asexual and sexual blood
stage as well as the liver stage of the Plasmodium parasite.
However, the downstream targets of PfPKG are unclear and
the question remains as to how cGMP signalling (through
PKG) is interwoven with the mechanisms known to regulate
egress of apicomplexan parasites.
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7.1. Interaction between cGMP and calcium signalling
pathways
Many of the processes that are regulated by cGMP are also
regulated by calcium and the two pathways are likely inter-
sected at more than one point. A family of plant like calcium-
dependent protein kinases (CDPKs) has been implicated in
the processes downstream of the intracellular calcium release
in Plasmodium. PfCDPK5 is believed to be involved in
regulating egress from late blood stage schizonts, since upon
inducible knockdown of PfCDPK5, rupture of mature
schizonts was blocked at a very late stage, but prior to PVM
and RBC membrane rupture, since these were still found
intact [45]. While both PfCDPK5-knockdown, as well as
pharmacological disruption of PfPKG, resulted in schizonts
unable to rupture, merozoites released from PfCDPK5-
knockdown schizonts were found to be viable, whereas
those released from PfPKG-inhibited schizonts were not
invasive [45], indicating that PfCDPK5 likely acts down-
stream of or in parallel to the egress cascade [45]. PfCDPK1
is also believed to have crucial functions in the maturation
and segmentation of asexual P. falciparum blood stage
parasites [46], although its position in any cascade is unclear.
In T. gondii, calcium signalling may act together with the
cGMP-dependent pathway in the regulation of microneme
secretion, where PKG was thought to be acting downstream
of calcium [44], since calcium ionophores were not able to
reverse the PKG inhibitor-dependent block of microneme
release.
Similar to the asexual schizont stage, interaction between
calcium- and cGMP-dependent signalling during gametogen-
esis has been suggested. In the current model of gametocyte
activation, XA was hypothesised to directly or indirectly
activate a membrane-bound GC, resulting in increased cGMP
levels which then stimulate gametogenesis through the actions
of PfPKG [34]. While intracellular calcium mobilisation
appeared to be required for exflagellation, raising intracellular
calcium with an ionophore was found not to be sufficient to
activate P. falciparum gametocytes [33]. It has also been
observed that compound 1 blocked rounding up of gameto-
cytes, while the calcium-chelator BAPTA-AM did not [35].
This suggested that cGMP signalling and PfPKG activity may
be mediating the initiation of gametogenesis and acting
upstream or independently of calcium release and likely
activation of CDPK4 [35]. Interestingly, XA-dependent
cGMP-synthesis in membrane fractions was inhibited by
addition of calcium [34], which might indicate a direct link
from calcium- to cGMP-mediated signalling. These examples
illustrate that the interaction between these two signalling
cascades is likely to be complex, but the molecular details are
unknown.
7.2. Involvement of PfPKG in regulation of the egress
protease cascade
While T. gondii tachyzoites replicate by endodyogeny,
which continuously produces invasive parasites, P.
falciparum replicates by schizogony, and as the intermediate
stages are not invasive, merozoite release must be tightly
controlled, since premature egress would be fatal. The
mechanisms of permeabilisation of the two enclosing
membranes, the PVM and host cell membrane, are still
largely unresolved, although discharge of secretory organ-
elles, the action of several proteases [47e49] and perforin-
like proteins [50] have been implicated. The subtilisin-like
serine protease PfSUB1 is thought to have an essential
function, since a gene deletion attempt was unsuccessful,
which is in line with the observation that pharmacological
inhibition of PfSUB1 activity blocks egress and ablates the
invasive capacity of merozoites [48]. PfSUB1 localises to
dense granule-like structures, termed exonemes, which are
present at the apical end of the individual merozoite [51].
Prior to egress, PfSUB1 is discharged into the PV lumen,
where it is believed to mediate proteolytic activation of
a family of papain-like serine rich antigen proteases
(SERAs), which have further roles in completing the egress
cascade [48]. Additional PfSUB1 substrates include PfMSP1,
6 and 7 [52] and proteomic and bioinformatic approaches
have implicated many more [53]. Inhibition of PKG with
compound 1 was found to completely block proteolytic
processing of PfMSP1 [45], but the compound did not have
a direct effect on PfSUB1 activity [45]. It was concluded that
PfPKG is likely involved in the initiation of the proteolytic
cascade that results in egress [45]. Interestingly, in contrast
to schizonts treated with the PKG inhibitors, processing of
PfMSP1 appeared unchanged in schizonts in which expres-
sion of PfCDPK5 had been knocked down, which also
pointed to PfCDPK5 acting downstream of PfPKG or in
a parallel pathway [45]. In immunofluorescence studies,
PfSUB1 and PfMSP1 appeared to localise normally to the
apical tip of the individual merozoites in P. falciparum
schizonts treated with the PKG inhibitor compound 1 [29],
suggesting that PfPKG is not involved in the trafficking of
the protease or its substrate to their respective compartments.
In T. gondii tachyzoites, compound 1 blocked secretion of
micronemal adhesins, which the parasite uses to attach to
host cells for gliding and invasion, and as a result motility
and cell invasion were also inhibited at a similar efficiency to
that of the protein kinase inhibitor staurosporine [44]. Since
this phenotype was absent in parasites that express the
gatekeeper mutated TgPKG, which is resistant to inhibition
by compound 1, TgPKG was verified as the primary target of
compound 1 in this process, providing clear evidence for an
involvement of TgPKG in micronemal secretion [44],
although the molecular mechanism is still unresolved.
Investigation of a role for PfPKG in invasion is technically
difficult due to the block in egress resulting from PKG
inhibition. A role for the P. falciparum orthologue in the
regulation of exoneme discharge into the PV lumen has been
hypothesised [45,54]. It is of note that in Toxoplasma, there
is little information on the potential role of TgPKG in egress,
perhaps supporting the crucial role that PfPKG has in regu-
lating the correct timing of egress in Plasmodium, that may
not be essential in Toxoplasma.
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8. Concluding remarks
Evidence suggests that PKG regulates merozoite egress
from P. falciparum blood stage schizonts [30] and P. berghei
liver stage schizonts [42,43]. Regulatory roles have also been
found for PKG in the changes that take place in preparation for
gamete egress [35], as well as in P. berghei ookinete devel-
opment and motility [13]. The intracellular targets of PfPKG,
which as a consequence are key players in the progression of
the parasite life cycle, remain unknown. PKG probably has
numerous downstream substrates and since it is acting at
multiple stages of the parasite life cycle, it is likely to have
some functionally distinct, stage-specific substrates. As
advances are made in the field of phosphoproteomics and
specific analyses of PKG-dependent phosphoproteomes are
assembled we will be able to build a clearer picture of the
consequences, at the protein level, that arise from inhibition of
PKG, and how these relate to the phenotypic observations that
have arisen from genetic and chemical knockdown of PKG.
The reader is referred to a number of related articles on
Plasmodium biology in this special issue [55e64].
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